The Patent Finder

Terms ending in 2034

Sanofi

Every in-force patent on Sanofi's record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 9,186,346Methods for Reducing the Risk of an Adverse Teriflunomide and Rosuvastatin Interaction in Multiple Sclerosis Patients
In force
 · High confidence
SanofiIn forceHigh confidence
US 9,839,675Stabilized Pharmaceutical Formulations of Insulin Analogues And/Or Insulin Derivatives
In force
 · High confidence
SanofiIn forceHigh confidence
US 9,937,252Induction of Cross-Reactive Cellular Response Against Rhinovirus Antigens
In force
 · High confidence
Sanofi R&D VaccinsIn forceHigh confidence
US 12,331,294MicroRNA Compounds and Methods for Modulating MIR-21 Activity
In force
 · High confidence
SanofiIn forceHigh confidence
US 9,474,713Chewable Composition for Oral Administration and Process for Preparing Thereof
In force
 · High confidence
Opella Healthcare Group SASIn forceHigh confidence
US 9,440,941Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals
In force
 · High confidence
SanofiIn forceHigh confidence
US 9,718,825N-(4-(AZAINDAZOL-6-YL)-PHENYL)-SULFONAMIDES and Their Use as Pharmaceuticals
In force
 · High confidence
SanofiIn forceHigh confidence
US 9,663,524SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS PROTEIN KINASE INHIBITORS
In force
 · High confidence
Bristol-Myers Squibb CompanyIn forceHigh confidence
US 9,695,132Heteroaryl Compounds and Uses Thereof
In force
 · High confidence
Bristol-Myers Squibb CompanyIn forceHigh confidence
US 10,065,966SUBSTITUTED PYRIDO[2,3-d]PYRIMIDINES AS INHIBITORS OF PROTEIN KINASES
In force
 · High confidence
Bristol-Myers Squibb CompanyIn forceHigh confidence
51 more term ends in 2034 · Pro
10 of 61 patents shown. Soonest term end first, then patent number.
Pro members see all 61.
Upgrade to Pro
45 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited